YIV-906 enhances nuclear factor of activated T-cells (NFAT) activity of T cells and promotes immune checkpoint blockade antibody action and CAR T-cell activity

• Principais autores: Wing Lam (Autor), Rong Hu (Autor), Shwu-Huey Liu (Autor), Peikwen Cheng (Autor), Yung-Chi Cheng (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

YIV-906 is a systems biology botanical cancer drug, inspired by a traditional Chinese herbal formulation. Results from eight Phase I/II to II clinical studies demonstrated the potential of YIV-906 to prolong survival and improve the quality of life of cancer patients. As an immunomodulator in the tu...